1. Home
  2. DXCM vs LDOS Comparison

DXCM vs LDOS Comparison

Compare DXCM & LDOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DXCM
  • LDOS
  • Stock Information
  • Founded
  • DXCM 1999
  • LDOS 1969
  • Country
  • DXCM United States
  • LDOS United States
  • Employees
  • DXCM N/A
  • LDOS N/A
  • Industry
  • DXCM Medical/Dental Instruments
  • LDOS EDP Services
  • Sector
  • DXCM Health Care
  • LDOS Technology
  • Exchange
  • DXCM Nasdaq
  • LDOS Nasdaq
  • Market Cap
  • DXCM 31.7B
  • LDOS 21.0B
  • IPO Year
  • DXCM 2005
  • LDOS 2006
  • Fundamental
  • Price
  • DXCM $70.74
  • LDOS $189.09
  • Analyst Decision
  • DXCM Strong Buy
  • LDOS Strong Buy
  • Analyst Count
  • DXCM 20
  • LDOS 13
  • Target Price
  • DXCM $96.40
  • LDOS $193.75
  • AVG Volume (30 Days)
  • DXCM 4.4M
  • LDOS 752.2K
  • Earning Date
  • DXCM 10-30-2025
  • LDOS 11-04-2025
  • Dividend Yield
  • DXCM N/A
  • LDOS 0.84%
  • EPS Growth
  • DXCM N/A
  • LDOS 233.94
  • EPS
  • DXCM 1.43
  • LDOS 10.58
  • Revenue
  • DXCM $4,300,800,000.00
  • LDOS $17,053,000,000.00
  • Revenue This Year
  • DXCM $17.01
  • LDOS $5.17
  • Revenue Next Year
  • DXCM $15.36
  • LDOS $3.59
  • P/E Ratio
  • DXCM $49.18
  • LDOS $17.95
  • Revenue Growth
  • DXCM 9.30
  • LDOS 6.53
  • 52 Week Low
  • DXCM $57.52
  • LDOS $123.62
  • 52 Week High
  • DXCM $93.25
  • LDOS $202.90
  • Technical
  • Relative Strength Index (RSI)
  • DXCM 55.48
  • LDOS 51.62
  • Support Level
  • DXCM $63.20
  • LDOS $180.45
  • Resistance Level
  • DXCM $71.96
  • LDOS $193.72
  • Average True Range (ATR)
  • DXCM 2.01
  • LDOS 4.63
  • MACD
  • DXCM 0.97
  • LDOS -0.52
  • Stochastic Oscillator
  • DXCM 85.01
  • LDOS 45.88

About DXCM DexCom Inc.

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

About LDOS Leidos Holdings Inc.

Leidos Holdings Inc is a technology, engineering, and science company that provides services and solutions in the defense, intelligence, civil, and health markets, both domestically and internationally. Company customer includes the U.S. Department of Defense ("DoD"), the U.S. Intelligence Community, the U.S. Department of Homeland Security ("DHS"), the Federal Aviation Administration ("FAA"), the Department of Veterans Affairs ("VA"), and many other U.S. civilian, state and local government agencies, etc. The company is engaged in four reportable segments; National Security & Digital, Health & Civil, Commercial & International and Defense Systems. It provides a wide array of scientific, engineering and technical services and solutions across these reportable segments.

Share on Social Networks: